Caribou Biosciences CRBU
Caribou Biosciences, Inc. (the Company) issued 26,234,654 shares of its common stock
- Form
- 8-K
- Filed
- Period
- Importance
- Major
- Accession
- 0001193125-21-227378
- Document
- 8-K
- Exhibit 10.1
- Material contract
- Exhibit 10.2
- Material contract
- Exhibit 10.3
- Material contract
- Exhibit 10.4
- Material contract
- Sells unregistered shares (3.02)
- Reports an executive or board change (5.02)
- Amends its charter or bylaws (5.03)
- Discloses other events (8.01)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.
- Protara Therapeutics PRTO public float $112M, Jun 30, 2025
- Fate Therapeutics FATE public float $113M, Jun 30, 2025
- Protalix BioTherapeutics PLX public float $113M, Jun 30, 2025
- TuHURA Biosciences HURA public float $111M, Jun 30, 2025
- Enanta Pharmaceuticals ENTA public float $111M, Mar 31, 2025, over 18 months old